Statistics
Publications
14
Citations
522
H-Index
12
Active since
2009
Weiran Xu is an author at Peking University specializing in oncology, medicine, and immunotherapy.
Publications per year
2009–2023
14
14
Adverse reactions of sorafenib, sunitinib, and imatinib in treating digestive system tumors
Xing Wei, Lin Li, Weiran Xu et al. · Thoracic Cancer · 2018 · 33 citations · Full text
Medicine, Oncology, Pharmacology +13
1–5 of 14